CTI BioPharma to Receive $10 Million Milestone Payment for TRISENOX®

January 17, 2018

Responsive image

SEATTLE, Jan. 18, 2018 /PRNewswire/ — CTI BioPharma Corp. (NASDAQ and MTA:CTIC) today announced that it expects to receive a $10 million milestone payment in February, 2018 from Teva Pharmaceutical Industries Ltd.  related to the achievement of a milestone for U.S. Food and Drug…

Category: Precious Metals